Harvard Bioscience
HBIO
#10404
Rank
A$63.94 M
Marketcap
A$13.98
Share price
2.88%
Change (1 day)
1,374.27%
Change (1 year)

Earnings for Harvard Bioscience (HBIO)

Earnings in 2026 (TTM): -A$15.47 Million

According to Harvard Bioscience's latest financial reports the company's current earnings are A$87.8 Million. In 2025 the company made an earning of -A$84.66 Million a decrease over its 2024 earnings that were of -A$17.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harvard Bioscience from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$15.47 Million-81.73%
2025 -A$84.66 Million391.95%
2024 -A$17.21 Million356.38%
2023 -A$3.78 Million-72.15%
2022 -A$13.54 Million6456.43%
2021 -A$0.21 Million-98.08%
2020 -A$10.76 Million32.53%
2019 -A$8.12 Million-31.01%
2018 -A$11.77 Million243.9%
2017 -A$3.43 Million-24.66%
2016 -A$4.55 Million-14.69%
2015 -A$5.33 Million-181.68%
2014 A$6.51 M-9.97%
2013 A$7.23 M120%
2012 A$3.28 M-50.9%
2011 A$6.69 M-52.51%
2010 A$14.1 M-2.53%
2009 A$14.47 M28.26%
2008 A$11.28 M-20.05%
2007 A$14.11 M13.96%
2006 A$12.38 M17.59%
2005 A$10.53 M57.37%
2004 A$6.69 M-37.31%
2003 A$10.67 M208.03%
2002 A$3.46 M-168.71%
2001 -A$5.05 Million-66.89%
2000 -A$15.24 Million